Consolidated Statement Of Income

Chordia Therapeutics,Inc - Filing #7293580

Concept	2023-09-01 to 2024-08-31	2023-09-01 to 2024-08-31	2023-09-01 to 2024-08-31	2023-09-01 to 2024-08-31	2022-09-01 to 2023-08-31	2022-09-01 to 2023-08-31	2022-09-01 to 2023-08-31	2022-09-01 to 2023-08-31
Consolidated statement of income
Statement of income
Operating expenses
Selling, general and administrative expenses	—	—	—	—	—	—	—	—
Depreciation	925,000 JPY	—	—	—	—	—	3,951,000 JPY	—
Taxes and dues	52,115,000 JPY	—	—	—	—	—	439,000 JPY	—
Operating expenses
Operating expenses - general
Remuneration for directors (and other officers)	45,000,000 JPY	—	—	—	—	—	49,200,000 JPY	—
Operating expenses
Ordinary profit (loss)	-1,824,707,000 JPY	—	—	—	—	—	225,761,000 JPY	—
Operating profit (loss)	-1,801,396,000 JPY	—	—	—	—	—	212,057,000 JPY	—
General and administrative expenses
Salaries	—	—	—	—	—	—	—	—
Operating expenses
Selling, general and administrative expenses
Non-operating income
Other	104,000 JPY	—	—	—	—	—	562,000 JPY	—
Non-operating income	17,831,000 JPY	—	—	—	—	—	25,948,000 JPY	—
Non-operating expenses
Other	JPY	—	—	—	—	—	0 JPY	—
Non-operating expenses	41,142,000 JPY	—	—	—	—	—	12,243,000 JPY	—
Share issuance costs	8,745,000 JPY	—	—	—	—	—	JPY	—
Profit (loss) before income taxes	-1,824,707,000 JPY	—	—	—	—	—	225,761,000 JPY	—
Income taxes - current	2,420,000 JPY	—	—	—	—	—	2,420,000 JPY	—
Income taxes	2,420,000 JPY	—	—	—	—	—	2,420,000 JPY	—
Profit (loss)	-1,827,127,000 JPY	-1,827,127,000 JPY	-1,827,127,000 JPY	-1,827,127,000 JPY	223,341,000 JPY	223,341,000 JPY	223,341,000 JPY	223,341,000 JPY